150 related articles for article (PubMed ID: 17348082)
1. A covariate adjusted two-stage allocation design for binary responses in randomized clinical trials.
Bandyopadhyay U; Biswas A; Bhattacharya R
Stat Med; 2007 Oct; 26(24):4386-99. PubMed ID: 17348082
[TBL] [Abstract][Full Text] [Related]
2. An urn model for odds-ratio-based response-adaptive phase III clinical trials for two or more treatments.
Basak GK; Biswas A; Volkov S
J Biopharm Stat; 2009 Sep; 19(5):838-56. PubMed ID: 20183447
[TBL] [Abstract][Full Text] [Related]
3. Covariate-adjusted adaptive designs for continuous responses in a phase III clinical trial: recommendation for practice.
Biswas A; Huang HH; Huang WT
J Biopharm Stat; 2006; 16(2):227-39. PubMed ID: 16584069
[TBL] [Abstract][Full Text] [Related]
4. An urn based covariate adjusted response adaptive allocation design.
Bandyopadhyay U; Bhattacharya R
Stat Methods Med Res; 2012 Apr; 21(2):135-48. PubMed ID: 22287603
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of treatment response in depression studies using a Bayesian parametric cure rate model.
Santen G; Danhof M; Della Pasqua O
J Psychiatr Res; 2008 Oct; 42(14):1189-97. PubMed ID: 18353370
[TBL] [Abstract][Full Text] [Related]
6. Stratified and randomized play-the-winner rule.
Liang Y; Carriere KC
Stat Methods Med Res; 2008 Dec; 17(6):581-93. PubMed ID: 18375460
[TBL] [Abstract][Full Text] [Related]
7. Bayesian methods for analysis of binary outcome data in cluster randomized trials on the absolute risk scale.
Thompson SG; Warn DE; Turner RM
Stat Med; 2004 Feb; 23(3):389-410. PubMed ID: 14748035
[TBL] [Abstract][Full Text] [Related]
8. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
Morgan CC; Stephen Coad D
Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
[TBL] [Abstract][Full Text] [Related]
9. Bayesian adaptive biased-coin designs for clinical trials with normal responses.
Atkinson AC; Biswas A
Biometrics; 2005 Mar; 61(1):118-25. PubMed ID: 15737084
[TBL] [Abstract][Full Text] [Related]
10. A comparison of several approaches for choosing between working correlation structures in generalized estimating equation analysis of longitudinal binary data.
Shults J; Sun W; Tu X; Kim H; Amsterdam J; Hilbe JM; Ten-Have T
Stat Med; 2009 Aug; 28(18):2338-55. PubMed ID: 19472307
[TBL] [Abstract][Full Text] [Related]
11. Covariate-adjusted response-adaptive designs for binary response.
Rosenberger WF; Vidyashankar AN; Agarwal DK
J Biopharm Stat; 2001 Nov; 11(4):227-36. PubMed ID: 12018777
[TBL] [Abstract][Full Text] [Related]
12. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of ordinal outcomes using individual patient data.
Whitehead A; Omar RZ; Higgins JP; Savaluny E; Turner RM; Thompson SG
Stat Med; 2001 Aug; 20(15):2243-60. PubMed ID: 11468762
[TBL] [Abstract][Full Text] [Related]
14. Sequential urn designs with elimination for comparing K > or =3 treatments.
Coad DS; Ivanova A
Stat Med; 2005 Jul; 24(13):1995-2009. PubMed ID: 15803441
[TBL] [Abstract][Full Text] [Related]
15. Bayesian decision sequential analysis with survival endpoint in phase II clinical trials.
Zhao L; Woodworth G
Stat Med; 2009 Apr; 28(9):1339-52. PubMed ID: 19226557
[TBL] [Abstract][Full Text] [Related]
16. Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.
Yin G; Li Y; Ji Y
Biometrics; 2006 Sep; 62(3):777-84. PubMed ID: 16984320
[TBL] [Abstract][Full Text] [Related]
17. A bayesian dose-finding design adapting to efficacy and tolerability response.
Padmanabhan SK; Berry S; Dragalin V; Krams M
J Biopharm Stat; 2012; 22(2):276-93. PubMed ID: 22251174
[TBL] [Abstract][Full Text] [Related]
18. Adaptive allocation for binary outcomes using decreasingly informative priors.
Sabo RT
J Biopharm Stat; 2014; 24(3):569-78. PubMed ID: 24697793
[TBL] [Abstract][Full Text] [Related]
19. An orwellian discourse on the meaning and measurement of noninferiority.
Diamond GA; Kaul S
Am J Cardiol; 2007 Jan; 99(2):284-7. PubMed ID: 17223435
[TBL] [Abstract][Full Text] [Related]
20. Prescribing antidepressants to advanced cancer patients with mild depressive symptoms is not justified.
Coyne JC; Palmer SC; Shapiro PJ
J Clin Oncol; 2004 Jan; 22(1):205-6; author reply 206-8. PubMed ID: 14701791
[No Abstract] [Full Text] [Related]
[Next] [New Search]
